Skip to content

Research at St Andrews

Friend or enemy? Review of 17β‐HSD10 and its role in human health or disease

Research output: Contribution to journalReview articlepeer-review

DOI

Open Access Status

  • Embargoed (until 23/05/21)

Abstract

17β‐hydroxysteroid dehydrogenase (17β‐HSD10) is a multifunctional human enzyme with important roles both as a structural component and also as a catalyst of many metabolic pathways. This mitochondrial enzyme has important functions in the metabolism, development and aging of the neural system, where it is involved in the homeostasis of neurosteroids, especially in regard to estradiol, changes in which make it an essential part of neurodegenerative pathology. These roles therefore, indicate that 17β‐HSD10 may be a possible druggable target for neurodegenerative diseases including Alzheimer’s disease (AD), and in hormone dependent cancer. The objective of this review is to provide a summary about physiological functions and pathological roles of 17β‐HSD10 and the modulators of its activity.
Close

Details

Original languageEnglish
JournalJournal of Neurochemistry
VolumeEarly view
Early online date23 May 2020
DOIs
Publication statusE-pub ahead of print - 23 May 2020

    Research areas

  • 17β-hydroxysteroid dehydrogenase type 10, Alzheimer’s disease, Cancer, Estradiol, HSD10, Neurosteroid

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Neuroprotective actions of leptin facilitated through balancing mitochondrial morphology and improving mitochondrial function

    Cheng, Y., Buchan, M., Vitanova, K., Aitken, L., Gunn-Moore, F. J., Ramsay, R. R. & Doherty, G., 13 Oct 2020, In: Journal of Neurochemistry. 155, 2, p. 191-206 e15003.

    Research output: Contribution to journalArticlepeer-review

  2. Willin/FRMD6 influences mechanical phenotype and neuronal differentiation in mammalian cells by regulating ERK1/2 activity

    Kronenberg, N. M., Tilston-Lunel, A., Thompson, F. E., Chen, D., Yu, W., Dholakia, K., Gather, M. C. & Gunn-Moore, F. J., 4 Sep 2020, In: Frontiers in Cellular Neuroscience. 14, 11 p., 552213.

    Research output: Contribution to journalArticlepeer-review

  3. Brain region–specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer’s disease

    Dey, M., Gunn-Moore, F. J., Platt, B. & Smith, T. K., 31 Aug 2020, In: Lipids in Health and Disease. 19, 17 p., 201.

    Research output: Contribution to journalArticlepeer-review

  4. Nanostructural diversity of synapses in the mammalian spinal cord

    Broadhead, M. J., Bonthron, C., Arcinas, L., Bez, S., Zhu, F., Goff, F. E., Nylk, J., Dholakia, K., Gunn-Moore, F. J., Grant, S. G. N. & Miles, G. B., 18 May 2020, In: Scientific Reports. 10, 18 p., 8189.

    Research output: Contribution to journalArticlepeer-review

  5. Benzothiazolyl ureas are low micromolar and uncompetitive inhibitors of 17β-HSD10 with implications to Alzheimer’s disease treatment

    Schmidt, M., Benek, O., Vinklarova, L., Hrabinova, M., Zemanova, L., Chribek, M., Kralova, V., Hroch, L., Dolezal, R., Lycka, A., Prchal, L., Jun, D., Aitken, L., Gunn-Moore, F., Kuca, K. & Musilek, K., 17 Mar 2020, In: International Journal of Molecular Sciences. 21, 6, 26 p., 2059.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Neuroprotective actions of leptin facilitated through balancing mitochondrial morphology and improving mitochondrial function

    Cheng, Y., Buchan, M., Vitanova, K., Aitken, L., Gunn-Moore, F. J., Ramsay, R. R. & Doherty, G., 13 Oct 2020, In: Journal of Neurochemistry. 155, 2, p. 191-206 e15003.

    Research output: Contribution to journalArticlepeer-review

  2. Synaptic vesicle exocytosis and increased cytosolic calcium are both necessary but not sufficient for activity-dependent bulk endocytosis

    Morton, A., Marland, J. R. K. & Cousin, M. A., Aug 2015, In: Journal of Neurochemistry. 134, 3, p. 405-415 11 p.

    Research output: Contribution to journalArticlepeer-review

  3. Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease

    Zilberter, M., Ivanov, A., Ziyatdinova, S., Mukhtarov, M., Malkov, A., Alpar, A., Tortoriello, G., Botting, C. H., Fueloep, L., Osypov, A. A., Pitkanen, A., Tanila, H., Harkany, T. & Zilberter, Y., Apr 2013, In: Journal of Neurochemistry. 125, 1, p. 157-171 15 p.

    Research output: Contribution to journalArticlepeer-review

  4. Phospholipase C-η2 is required for retinoic acid-stimulated neurite growth

    Popovics, P., Gray, A., Arastoo, M., Finelli, D. K., Tan, A. J. L. & Stewart, A. J., Mar 2013, In: Journal of Neurochemistry. 124, 5, p. 632-644 13 p.

    Research output: Contribution to journalArticlepeer-review

ID: 267545996

Top